867 results about "Genetic stability" patented technology

The present invention relates to the fermentation process of producing L-arginine. By using Corynebacterium crenatum SYA5 screened and preserved by the present lab as parent and through conventional physical and chemical mutation process and multiple structural analog resistance screening, mutant strain SDNN403 is obtained. Through culturing of the mutant strain under optimized condition, L-arginine is produced in the yield level of 30-35 g/L. The strain has high genetic stability, stable yield characteristic, high L-arginine yield level, less produced hetero acids and easy technological amplification, and is suitable four industrial production.

The invention provides an acid-resistant bifidobacterium breve BB8dpH and an application thereof. The nucleotide sequence of the 16SrRNA gene part of the bifidobacterium breve BB8dpH is shown in SEQ ID NO.1, and is stored with the preservation number of CGMCCNo.8370. The bifidobacterium breve BB8dpH is a strain obtained by separating from the dejecta of healthy young people and further screening under the pH 3.2 acid condition. According to the fermentation and culturing process, anaerobic culture at 37 DEG C is carried out in a BL liquid substrate (containing 0.05% cysteine hydrochloride) for 24 hours. The bifidobacterium breve BB8dpH has remarkably better acid resistance than the common strains, and the acid resistance has genetic stability; the bifidobacterium breve BB8dpH has different percent contents of cell membrane fatty acids from the common strains, the average carbon chain length of the bifidobacterium breve BB8dpH is remarkably longer than that of the common strains, and the cell membrane fluidity of the bifidobacterium breve BB8dpH is remarkably lower than that of the common strains; and the bifidobacterium breve BB8dpH is used in the production field of daily fermented food, health-care food and medicines.

A vaccine comprising an immunologically effective amount of recombinant modified vaccinia Ankara (rMVA) virus which is genetically stable after serial passage and produced by a) constructing a transfer plasmid vector comprising a modified H5 (mH5) promoter operably linked to a DNA sequence encoding a heterologous foreign protein antigen, wherein the expression of said DNA sequence is under the control of the mH5 promoter; b) generating rMVA virus by transfecting one or more plasmid vectors obtained from step a) into wild type MVA virus; c) identifying rMVA virus expressing one or more heterologous foreign protein antigens using one or more selection methods for serial passage; d) conducting serial passage; e) expanding an rMVA virus strain identified by step d); and f) purifying the rMVA viruses from step e) to form the vaccine. One embodiment is directed to a fusion cytomegalovirus (CMV) protein antigen comprising a nucleotide sequence encoding two or more antigenic portions of Immediate-Early Gene-1 or Immediate-Early Gene-2 (IEfusion), wherein the antigenic portions elicit an immune response when expressed by a vaccine.

The invention provides a method for performing GINS2 gene editing on mesenchymal stem cells by adopting a CRISPR-cas 9 system, and particularly relates to a method for constructing a GINS2 gene-knocked mesenchymal stem cell line. A new enhancin CREnhancer 1.0 is used, so that the editing efficiency of the CRISPR-cas 9 gene in cells can be remarkably improved. The GINS2 knockout plasmid for the mesenchymal stem cells provided by the invention has high genetic stability.

The invention provides RBM17 gene edition carried out on mesenchymal stem cells by adopting a CRISPR-CAS system and in particular relates to construction of a mesenchymal stem cell line with the RBM17gene knocked out. A new enhancing CREnhancer1.0 is used, and intracellular CRISPR/Cas9 gene editing efficiency can be obviously improved. The mesenchymal stem cell RBM17 knockout plasmid provided bythe invention has better genetic stability.

The invention provides CNE10 gene editing for epidermal stem cells by using a CRISPR-Cas system, and particularly relates to establishment of an epidermal stem cell system with GNE10 gene knocked out.Through the establishment, two specific gRNA (guide ribose nucleic acids) are obtained, editing efficiency of the CRISPR-Cas system aiming at the GNE10 gene in the epidermal stem cells can be increased remarkably. An obtained epidermal stem cell plasmid with CNE10 gene knockout is good in hereditary stability and high in targeting efficiency.

The invention discloses a microbial compound preparation, a preparation method and a method for treating kitchen garbage. The method for treating kitchen garbage is to separate out mixed bacteria of bacteria and fungi with a certain ratio from the natural world and fermented food, and then prepare the mixed bacteria preparation to effectively treat the kitchen garbage. The preparation comprises the mixed bacteria including various bacteria, actinomycetes, yeast and mycetes. The preparation is characterized in that the mixed bacteria further comprise bacillus subtilis, bacillus licheniformis, high-temperature monad, streptomycete, lactobacillus plantarum, lactobacillus acidophilus, brewer's yeast, pichia pastoris, aroma-producing yeast, rhizopus chinensis, rhizopus oryzae and mucor indicus. The preparation is good for treating the kitchen garbage, non-toxic, harmless, and of genetic stability.

The invention discloses a recombinant low-virulent vaccine strain of chicken infectious bursal disease viruses (IBDV) and application thereof. In the invention, a major protective antigen gene VP2 of an epidemic superhigh virulent strain is cloned, the nucleotide of the gene VP2 is modified by mutation and then used for replacing a corresponding segment of a Gt genome of a low-virulent strain of the IBDV, so that the infectious clone of a recombinant genome of the IBDV is constructed, and the recombinant low-virulent vaccine strain is saved and identified by using an IBDV reverse genetic operation system. The microbial collection number of the vaccine strain is CGMCC No.3749. The recombinant low-virulent vaccine strain of the invention has high replicability, genetic stability and safety. The immune effect of the low-virulent vaccine strain of the invention is as good as that of the medium-virulent vaccine strain, but is superior to that of the low-virulent vaccine strain. The biological safety of the low-virulent vaccine strain of the invention is superior to that of the medium-virulent vaccine strain. As the vaccine strain, the recombinant low-virulent vaccine strain of the invention has the characteristics of high efficiency and low toxicity, is a good candidate vaccine strain and can be used for controlling chicken infectious bursal disease.

The invention provides a mutagenic strain of cordyceps militaris and a breeding method. A new high-yield strain of cordyceps militaris is obtained by chemical mutagenesis, the preservation number thereof is CGMCC NO. 2909, and compared with original starting strain, the dry weight of mycelium is increased by 103%, the content of adenosine is increased by 536%, the content of polysaccharide is increased by 22.2%, the content of protein is increased by 55.5%, and the content of mannitol is increased by 37.5 %. The new strain of cordyceps militaris does not degenerate after more than 20 times of subculturing, has genetic stability, and utilizes the research of random amplified polymorphic DNA (RAPD) to verify the difference on DNA level between the strain and the original starting strain. The invention also discloses the optimum process condition for extracting polysaccharide and adenosine of cordyceps militaris.

The invention discloses a method for establishment of a hybrid strain between bluntsnout bream and topmouth culter. The bluntsnout bream is used as a female parent, the topmouth culter is used as a male parent, the hybrid strain F1 of the bluntsnout bream and the topmouth culter is obtained through distant hybridization and is then bred and tested to obtain a bisexual fertile F1; then F1 is cultured as an object, selfing of the bisexual fertile F1 is performed, and a diploid F2 of the bluntsnout bream and the topmouth culter is obtained through incubation and breeding; and the ploidy and sterility of F2 are tested to obtain a bisexual fertile F2, and thus the heterologous bream and culter stain with genetic stability and bisexual sterility is obtained. The invention also discloses a breeding method of topmouth bream. The bisexual fertile diploid hybrid strain F1 of the bluntsnout bream and the topmouth culter and the bisexual fertile F2 of the bluntsnout bream and the topmouth culter are obtained by the establishment method, and backcross breeding is performed with the bluntsnout bream to obtain the hybrid topmouth bream. By adopting the breeding method, the novel hybrid topmouth bream with characteristics of high growth speed, high resistance, high meat quality, attractive shape and the like can be prepared.

An in vitro storage method for the germplasm resource of chrysanthemum includes such steps as taking the root bud of chrysanthemum as explant, secondary culture of auxiliary bud, and storing in the MS culture medium containing abscisic acid, 6-BA and NAA. Its survival rate after 10 months is 100%.

Disclosed is the high quality germchit tissure culturing and rapid breeding method of Dendrobium sp., wherein a large amount of test tube seedlings with stabilized performance are obtained through fine breed tissue culture by adopting the path of clumping buds. The produced Dendrobium sp. has the advantages of high genetic stability, quick emergence of seedlings, strong seedlings, good seedling quality, strong resistance, and fine growth status.

The invention discloses a feruloyl-esterase-producing Bacillus licheniformis strain and application thereof. The collection number of the Bacillus licheniformis DBM12 strain is CGMCC No.8672. The Bacillus licheniformis strain has the advantages of lower requirements for the carbon source and nitrogen source, short fermentation time, high safety and no toxicity, and can be used in food/feed industry. The Bacillus licheniformis strain has favorable hereditary stability, and is simple to operate. The feruloyl esterase synthesis capacity is basically unchanged after serial passage by more than 10 generations.

A method for producing a grosvenor momordica tissue culture seedling by a single culture medium uses an MS solid medium during the producing process and is characterized in that the angustimycin of 0.1 to 0.5mg L<1> is added into a normal MS solid medium to produce the grosvenor momordica tissue culture seedling. As the medium singly prepared by the angustimycin can be simultaneously used on each technical tache of 'axillary bud explant starting', 'proliferation and expanding propagation' and 'proliferated seedling rooting', thereby greatly simplifying the producing operation procedures of the grosvenor momordica tissue culture seedling. In particular, the angustimycin can effectively control the generation of a callus during the culturing process of the grosvenor momordica tissue culture seedling in particular, which is beneficial to the genetic stability; thereby improving the quality of the tissue culture seedling.

The invention relates to a protoplast mutation breeding method for improving the cordycepin content of cordyceps militaris. The method comprises the following steps of activated culture of bacterial strains, solid culture of mycelia, liquid mycelia culture, mycelia enzymolysis, protoplast nitrosoguanidine (NTG) mutation, protoplast regeneration culture, regenerated bacteria subculture, fermentation culture, filtering, further washing of mycelia, measurement of cordycepin content in the mycelia, preservation of the bacteria strain with high cordycepin content, measurement of the genetic stability and the like. Due to the adoption of the method, the cordycepin content of the cordyceps militaris can be increased.

The invention discloses a tissue-culture rapid propagation method for pyrus betulaefolia bunge. The tissue-culture rapid propagation method for the pyrus betulaefolia bunge comprises disinfecting on explants, inducing buds, propagating test tube seedlings, inducing calluses, inducing rooting and transplanting exercising seedlings. During the process of inducing rooting, the calluses are firstly induced and then the rooting is induced; obtained rooting test tube seedlings are performed seedling exercising in a triangular flask, then transferred to perlite to domesticate the exercising seedling and finally transplanted. Compared with the traditional method, the tissue-culture rapid propagation method for the pyrus betulaefolia bunge has the advantages of being high in rooting rate and survival rate of transplanting, high in propagation rate, low in cost, convenient to popularize, good in genetic stability and suitable for the pyrus betulaefolia bunge.

The invention discloses a micropropagation method of fraxinus rhynchophylla and relates to the micropropagation method. The problems of long reproductive cycle, low reproduction efficiency and poor offspring genetic stability in nursery stock propagation of fraxinus rhynchophylla are solved. The method comprises the following steps of: 1, sterilizing fraxinus rhynchophylla seeds, and culturing single cotyledons of zygotic embryos to obtain cotyledonal cell embryos; 2, performing maturation cultivation on the cotyledonal cell embryos; 3, performing sprouting cultivation on the cotyledonal cellembryos subjected to maturation cultivation to obtain regenerated plants; and 4, transplanting the regenerated plants into a culture medium to culture until new leaves are completely unfolded, and removing a covered plastic thin film. The micropropagation method has the advantages of short nursery stock reproductive cycle, high reproductive rate (culturing for 60 to 70 days) and high reproductionefficiency (each explant can generate 15 to 20 somatic embryos); the germination rate of the somatic embryos is up to 87 to 89.55 percent; the transplanting survival rate of the regenerated plants isup to 75 to 80 percent; and the regeneration plants with the same good characteristics as female parents can be generated in mass.

The present invention provides a screen preparing method of excellent enterococcus faecalis and its application. Enterococcus faecalis is the most common representative species in the Enterococcus, living in human intestinal, having no hazard to human, and having benefits. But Enterococcus faecali arises server infection some time, and having resistance to antibiotics. The invention repeatedly cultures and screens enterococcus faecalis, selecting out a strain which has exuberant life, quick growth speed, high fermentation unit, short fermentation cycle, high content of fermentation product, strength production adaptability as a producing strain by researching the contents of morphological characteristics, culture characteristics, physiological and biochemical response, metabolites, genetic character and protein expression, genetic stability, pilot producing index etc, forming a scale production. The broth has functions of immunity adjustment, antitumor etc.